164 related articles for article (PubMed ID: 24620809)
1. Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum.
Buscher B; Laakso S; Mascher H; Pusecker K; Doig M; Dillen L; Wagner-Redeker W; Pfeifer T; Delrat P; Timmerman P
Bioanalysis; 2014 Mar; 6(5):673-82. PubMed ID: 24620809
[TBL] [Abstract][Full Text] [Related]
2. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.
Higton D; Young G; Timmerman P; Abbott R; Knutsson M; Svensson LD
Bioanalysis; 2012 Nov; 4(22):2669-79. PubMed ID: 23210650
[TBL] [Abstract][Full Text] [Related]
3. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum.
Timmerman P; Anders Kall M; Gordon B; Laakso S; Freisleben A; Hucker R
Bioanalysis; 2010 Jul; 2(7):1185-94. PubMed ID: 21083233
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
5. Best practices for metabolite quantification in drug development: updated recommendation from the European Bioanalysis Forum.
Timmerman P; Blech S; White S; Green M; Delatour C; McDougall S; Mannens G; Smeraglia J; Williams S; Young G
Bioanalysis; 2016 Jun; 8(12):1297-305. PubMed ID: 27217058
[TBL] [Abstract][Full Text] [Related]
6. European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development.
Timmerman P; Herling C; Stoellner D; Jaitner B; Pihl S; Elsby K; Henderson N; Barroso B; Fischmann S; Companjen A; Versteilen A; Bates S; Kingsley C; Kunz U;
Bioanalysis; 2012 Aug; 4(15):1883-94. PubMed ID: 22943619
[TBL] [Abstract][Full Text] [Related]
7. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
Timmerman P; Luedtke S; van Amsterdam P; Brudny-Kloeppel M; Lausecker B; Fischmann S; Globig S; Sennbro CJ; Jansat JM; Mulder H; Thomas E; Knutsson M; Kasel D; White SA; Kall MA; Mokrzycki-Issartel N; Freisleben A; Romero F; Andersen MP; Knebel N; de Zwart M; Laakso S; Hucker RS; Schmidt D; Gordon B; Abbott R; Boulanger P
Bioanalysis; 2009 Sep; 1(6):1049-56. PubMed ID: 21083073
[TBL] [Abstract][Full Text] [Related]
8. Scientific or regulated validation: a tiered approach? Meeting report from a joint EBF/DVDMDG workshop.
Timmerman P; Lowes S; McDougall S; Colligon I; Miksic J; Chowdhury S; White S; Aubry AF; Jenkins R; Kemper C
Bioanalysis; 2015; 7(14):1703-10. PubMed ID: 26270777
[TBL] [Abstract][Full Text] [Related]
9. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis.
Freisleben A; Brudny-Klöppel M; Mulder H; de Vries R; de Zwart M; Timmerman P
Bioanalysis; 2011 Jun; 3(12):1333-6. PubMed ID: 21679027
[TBL] [Abstract][Full Text] [Related]
10. Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissues.
Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lenthéric I; McIntosh M; Dzygiel P; Timmerman P
Bioanalysis; 2014; 6(12):1617-26. PubMed ID: 25077623
[TBL] [Abstract][Full Text] [Related]
11. EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studies.
Pihl S; Michaut L; Hendriks J; Loebbert R; Ryding J; Nemansky M; Vermet L; Companjen A
Bioanalysis; 2014 May; 6(10):1409-13. PubMed ID: 24958124
[TBL] [Abstract][Full Text] [Related]
12. European Bioanalysis Forum continued plans to support liquid microsampling.
Timmerman P; White S; Cobb Z; Woods K; de Vries R; Spooner N; Sangster T; Dillen L; Hawthorne G
Bioanalysis; 2014; 6(14):1897-900. PubMed ID: 25158961
[No Abstract] [Full Text] [Related]
13. European Bioanalysis Forum: recommendation for dealing with internal standard variability.
White S; Adcock N; Elbast W; Hiller J; Knutsson M; Lausecker B; Long J; McDougall S; Salavert F; Sangster T; Verhaeghe T; van Amsterdam P
Bioanalysis; 2014 Oct; 6(20):2767-74. PubMed ID: 25413707
[TBL] [Abstract][Full Text] [Related]
14. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
[TBL] [Abstract][Full Text] [Related]
15. Feedback from the European Bioanalysis Forum liquid microsampling consortium: capillary liquid microsampling and assessment of homogeneity of the resultant samples.
Cobb Z; Rohde M; Love I; Boutet V; Schroeter K; Hawthorne G; Dillen L; Barfield M; Kandira A; Kranenborgh M; White S; Timmerman P
Bioanalysis; 2019 Mar; 11(6):525-532. PubMed ID: 30973017
[TBL] [Abstract][Full Text] [Related]
16. Tiered approach into practice: scientific validation for chromatography-based assays in early development - a recommendation from the European Bioanalysis Forum.
Timmerman P; White S; McDougall S; Kall MA; Smeraglia J; Fjording MS; Knutsson M
Bioanalysis; 2015 Sep; 7(18):2387-2398. PubMed ID: 26354595
[TBL] [Abstract][Full Text] [Related]
17. Recommendations from the European Bioanalysis Forum on method establishment for tissue homogenates.
Timmerman P; Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lentheric I; McIntosh M; Dzygiel P
Bioanalysis; 2014; 6(12):1647-56. PubMed ID: 25077625
[TBL] [Abstract][Full Text] [Related]
18. An update on the importance of plasma protein binding in drug discovery and development.
Di L
Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
[No Abstract] [Full Text] [Related]
19. Feedback from the European Bioanalysis Forum liquid microsampling consortium: microsampling: assessing accuracy and precision of handheld pipettes and capillaries.
Hawthorne G; Dillen L; Barfield M; Cobb Z; Kandira A; Schroeter K; White S; Karp NA; Love I; Boutet V; Rohde M; Kranenborgh M; Timmerman P
Bioanalysis; 2019 Mar; 11(6):533-542. PubMed ID: 30973018
[No Abstract] [Full Text] [Related]
20. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.
Ramanathan R; Jemal M; Ramagiri S; Xia YQ; Humpreys WG; Olah T; Korfmacher WA
J Mass Spectrom; 2011 Jun; 46(6):595-601. PubMed ID: 21630388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
